Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.2955 | -22.3169681309 | 5.805 | 5.9492 | 3.65 | 408698 | 4.11505838 | CS |
| 4 | -5.9208 | -56.7653854635 | 10.4303 | 14.9 | 3.65 | 1327010 | 8.83898063 | CS |
| 12 | -2.1505 | -32.2897897898 | 6.66 | 19.055 | 3.65 | 6820884 | 10.46239996 | CS |
| 26 | -17.2835 | -79.3075758271 | 21.793 | 24.2683 | 3.65 | 6352931 | 14.95662221 | CS |
| 52 | -302.0429 | -98.5289627483 | 306.5524 | 399.6 | 3.65 | 3547500 | 23.86793204 | CS |
| 156 | -12563.6505 | -99.9641196484 | 12568.16 | 13918.586 | 3.65 | 1366344 | 613.76850584 | CS |
| 260 | -938.4281 | -99.5217605067 | 942.9376 | 97680 | 3.65 | 1169893 | 7492.58000558 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
